Expanding the role of interventional oncology for advancing precision immunotherapy of solid tumors is a research paper published in Molecular Therapy — Oncolytics (2021). On theSindex it has a DataRank of 0. It has been cited 16 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01 CA235667
National Institutes of Health
Grant: P30 CA008748
National Cancer Institute
Grant: R01 CA236615-01
US Office of Congressionally Directed Medical Research Programs
Grant: LC160212
US Office of Congressionally Directed Medical Research Programs
Grant: CA170630
US Office of Congressionally Directed Medical Research Programs
Grant: BC132124
US Office of Congressionally Directed Medical Research Programs
Grant: CA190888
US Office of Congressionally Directed Medical Research Programs
Grant: CA180889
NCI NIH HHS
Grant: R01 CA236615
National Institutes of Health
Grant: 5R01CA236615-02
Image-guided irreversible electroporation directed CAR T-cell delivery to solid tumors
National Institutes of Health
Grant: 5R01CA235667-02
A phase I/II combination immunotherapy clinical trial: mesothelin-targeted chimeric antigen receptor T cells and checkpoint blockade agent in pleural mesothelioma
National Institutes of Health
Grant: 2P30CA008748-43
MOUSE GENETICS
Derfner Foundation
U.S. Department of Defense
Commonwealth Foundation for Cancer Research Foundation
Johnson and Johnson
Atara Biotherapeutics
Geoffrey Beene Foundation
Medtronic
FWCI
0.89
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals